Christiane R Hanke1, Carlos G Grijalva, Sopio Chochua, Mathias W Pletz, Claudia Hornberg, Kathryn M Edwards, Marie R Griffin, Hector Verastegui, Ana I Gil, Claudio F Lanata, Keith P Klugman, Jorge E Vidal. 1. From the *Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia; †Department of Health Policy, School of Medicine, Vanderbilt University, Nashville, Tennessee; ‡Center for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany; §Department of Environment and Health, School of Public Health, Bielefeld University, Bielefeld, Germany, ¶Vanderbilt Vaccine Research Program, Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee; and ‖Instituto de Investigación Nutricional, Lima, Perú.
Abstract
BACKGROUND: Pneumococcal conjugate vaccines (PCV) have decreased nasopharyngeal carriage of vaccine types but little data exist from rural areas. We investigated bacterial density, serotype distribution and antibiotic resistance of pneumococcal strains within the nasopharynx of young children in the Peruvian Andes, 2 years after PCV7 was introduced. METHODS: Pneumococcal strains were isolated from a subset of 125 children from our Peruvian cohort, who entered the study in 2009 and had pneumococcus detected in the nasopharynx in both 2009 and during follow-up in 2011. Strains were Quellung serotyped and tested for susceptibility to antibiotics. Bacterial density was determined by quantitative polymerase chain reaction. RESULTS: The prevalence of PCV7 strains decreased from 48% in 2009 to 28.8% in 2011, whereas non-PCV7 types increased from 52% to 71.2% (P = 0.002). There was a 3.5-fold increase in carriage of serotype 6C in 2011 (P = 0.026). Vaccination with PCV7 did not affect pneumococcal density in children colonized by a PCV7 type but did increase density in those colonized with a non-PCV7 type. Antibiotic resistance did not change after vaccine introduction; strains were nonsusceptible to tetracycline (97.2%), trimethoprim-sulfamethoxazole (56.4%), penicillin (34%), erythromycin (22.4%), chloramphenicol (18.8%) and clindamycin (12.4%). CONCLUSIONS: Serotype replacement was observed post-PCV7 vaccination with a concomitant, not previously recognized, increased nasopharyngeal density.
BACKGROUND:Pneumococcal conjugate vaccines (PCV) have decreased nasopharyngeal carriage of vaccine types but little data exist from rural areas. We investigated bacterial density, serotype distribution and antibiotic resistance of pneumococcal strains within the nasopharynx of young children in the Peruvian Andes, 2 years after PCV7 was introduced. METHODS:Pneumococcal strains were isolated from a subset of 125 children from our Peruvian cohort, who entered the study in 2009 and had pneumococcus detected in the nasopharynx in both 2009 and during follow-up in 2011. Strains were Quellung serotyped and tested for susceptibility to antibiotics. Bacterial density was determined by quantitative polymerase chain reaction. RESULTS: The prevalence of PCV7 strains decreased from 48% in 2009 to 28.8% in 2011, whereas non-PCV7 types increased from 52% to 71.2% (P = 0.002). There was a 3.5-fold increase in carriage of serotype 6C in 2011 (P = 0.026). Vaccination with PCV7 did not affect pneumococcal density in children colonized by a PCV7 type but did increase density in those colonized with a non-PCV7 type. Antibiotic resistance did not change after vaccine introduction; strains were nonsusceptible to tetracycline (97.2%), trimethoprim-sulfamethoxazole (56.4%), penicillin (34%), erythromycin (22.4%), chloramphenicol (18.8%) and clindamycin (12.4%). CONCLUSIONS: Serotype replacement was observed post-PCV7 vaccination with a concomitant, not previously recognized, increased nasopharyngeal density.
Authors: William P Hanage; Susan S Huang; Marc Lipsitch; Cynthia J Bishop; Daniel Godoy; Stephen I Pelton; Richard Goldstein; Heather Huot; Jonathan A Finkelstein Journal: J Infect Dis Date: 2006-12-27 Impact factor: 5.226
Authors: Catherine Satzke; Paul Turner; Anni Virolainen-Julkunen; Peter V Adrian; Martin Antonio; Kim M Hare; Ana Maria Henao-Restrepo; Amanda J Leach; Keith P Klugman; Barbara D Porter; Raquel Sá-Leão; J Anthony Scott; Hanna Nohynek; Katherine L O'Brien Journal: Vaccine Date: 2013-12-17 Impact factor: 3.641
Authors: Paul Turner; Jason Hinds; Claudia Turner; Auscharee Jankhot; Katherine Gould; Stephen D Bentley; François Nosten; David Goldblatt Journal: J Clin Microbiol Date: 2011-03-16 Impact factor: 5.948
Authors: Maria da Gloria S Carvalho; Maria Lucia Tondella; Karen McCaustland; Luciana Weidlich; Lesley McGee; Leonard W Mayer; Arnold Steigerwalt; Melissa Whaley; Richard R Facklam; Barry Fields; George Carlone; Edwin W Ades; Ron Dagan; Jacquelyn S Sampson Journal: J Clin Microbiol Date: 2007-05-30 Impact factor: 5.948
Authors: L E Redding; F Cubas-Delgado; M D Sammel; G Smith; D T Galligan; M Z Levy; S Hennessy Journal: Prev Vet Med Date: 2013-10-21 Impact factor: 2.670
Authors: Xueqing Wu; Nathan T Jacobs; Catherine Bozio; Preston Palm; Santiago M Lattar; Christiane R Hanke; David M Watson; Fuminori Sakai; Bruce R Levin; Keith P Klugman; Jorge E Vidal Journal: Appl Environ Microbiol Date: 2017-08-01 Impact factor: 4.792
Authors: Jorge E Vidal; Meagan N Wier; Uriel A Angulo-Zamudio; Erin McDevitt; Ana G Jop Vidal; Babek Alibayov; Anna Scasny; Sandy M Wong; Brian J Akerley; Larry S McDaniel Journal: Infect Immun Date: 2021-09-20 Impact factor: 3.441
Authors: Catherine G Sutcliffe; Lindsay R Grant; Emily Cloessner; Keith P Klugman; Jorge E Vidal; Raymond Reid; Janene Colelay; Robert C Weatherholtz; Sopio Chochua; Michael R Jacobs; Mathuram Santosham; Katherine L O'Brien; Laura L Hammitt Journal: Am J Epidemiol Date: 2019-12-31 Impact factor: 4.897
Authors: Roger R Fan; Leigh M Howard; Marie R Griffin; Kathryn M Edwards; Yuwei Zhu; John V Williams; Jorge E Vidal; Keith P Klugman; Ana I Gil; Claudio F Lanata; Carlos G Grijalva Journal: Emerg Infect Dis Date: 2016-11 Impact factor: 6.883
Authors: E L German; C Solórzano; S Sunny; F Dunne; J F Gritzfeld; E Mitsi; E Nikolaou; A D Hyder-Wright; A M Collins; S B Gordon; D M Ferreira Journal: Vaccine Date: 2019-06-05 Impact factor: 3.641
Authors: Kristin N Nelson; Carlos G Grijalva; Sopio Chochua; Paulina A Hawkins; Ana I Gil; Claudio F Lanata; Marie R Griffin; Kathryn M Edwards; Keith P Klugman; Jorge E Vidal Journal: Open Forum Infect Dis Date: 2018-02-17 Impact factor: 3.835